Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

University Hospital, Strasbourg, France

Status: Completed

Conditions: Non-Small Cell Lung Carcinoma; Small Cell Lung Cancer

Treatments: Procedure: Biopsy samples

Study type: Interventional

Funder types: Other

Identifiers

NCT00213798

2731

Details and patient eligibility

About

The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.
• No lung instability.
• Individuals give all informed consent

Trial design

Primary purpose: Screening

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)